President
Projections Research, Inc.
Dr Mould spent 30 years as a pharmacokineticist in industry specializing in population pharmacokinetic / pharmacodynamic modeling. She has conducted population PK/PD analyses of hematopoietic agents, monoclonal antibodies, anti-cancer and anti-viral agents, antipsychotic, cardiovascular, and sedative/hypnotic agents. Currently, Dr Mould is president of Projections Research Inc., a consulting company offering pharmacokinetic and pharmacometric services. She is the founder of Baysient LLC, a company that develops systems to individualize doses of drugs that are difficult to manage. She has published 96 peer-reviewed articles, 20 book chapters, made 127 national and international presentations and co-edited a textbook. Dr Mould has authored presented 112 posters at both national and international meetings. She is an adjunct professor at the University of Rhode Island, OSU, and the University of Florida, and teaches an annual class at the National Institutes of Health. She is a member of the editorial board for Journal of Pharmacokinetics and Pharmacodynamics, and Clinical Pharmacology and Therapeutics. She is a Fellow of the American College of Clinical Pharmacology and of the American Association of Pharmaceutical Sciences.